TAM
ACOR

THB Asset Management’s Acorda Therapeutics ACOR Stock Holding History

THB Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-323
Closed -$1.31M – 247
2014
Q3 		$1.31M Buy
+323
New +$1.21M 0.09% 206

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

THB Asset Management's ACOR Position: Q4 2014 in Review

THB Asset Management sold out of Acorda Therapeutics (ACOR) in Q4 2014, closing a stake of 323 shares — an estimated $1.31M sold.

THB Asset Management first reported a position in ACOR in Q3 2014 and held it in 1 quarter. The position peaked at $1.31M in Q3 2014. 179 funds tracked by Wall St. Rank hold ACOR as of Q4 2014.

  • THB Asset Management reported no remaining Acorda Therapeutics position as of Q4 2014 after selling out during the quarter.
  • THB Asset Management sold 323 Acorda Therapeutics shares in Q4 2014, an estimated $1.31M.
  • THB Asset Management first reported a position in Acorda Therapeutics in Q3 2014 and held it in 1 quarter.
  • THB Asset Management's Acorda Therapeutics position peaked at $1.31M in Q3 2014.
  • 179 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2014.

Based on THB Asset Management's 13F filing for Q4 2014, filed 30 Jan 2015.